Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the ...

The company reported that Palmetto GBA, a Medicare administrative contractor, has extended coverage for the test. This allows ...

On Thursday, Palmetto GBA, a MAC for Medicare's Molecular Diagnostics Services program (MolDX), finalized and maintained a non-coverage decision for DecisionDx-SCC, a genomic test to identify the ...

today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses diagnostic technologies through its Molecular Diagnostic Services Program (MolDX), has expanded coverage ...